Indaptus Therapeutics Inc logo

INDP

HEALTHCARE

Indaptus Therapeutics Inc

$2.05-0.04 (-1.91%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving INDP Today?

No stock-specific AI insight has been generated for INDP yet. Check back soon — insights are generated from recent news analysis.

52-Week Range

$1.51$19.91

$2.05

Fundamentals

Market Cap$5M
P/E Ratio
EPS$-21.58
Dividend Yield
Dividend / Share
ROE-5.9%
Profit Margin
Debt / Equity

Trading

Volume31K
Avg Volume (10D)
Shares Outstanding2.2M

INDP News

12 articles

All 12 articles loaded

Price Data

Open$2.05
Previous Close$2.09
Day High$2.18
Day Low$2.05
52 Week High$19.91
52 Week Low$1.51

About Indaptus Therapeutics Inc

Indaptus Therapeutics Inc. is a cutting-edge biotechnology firm focused on pioneering immunotherapies that aim to transform the landscape of cancer treatment. Utilizing a proprietary platform that enhances the immune system's capacity to identify and destroy tumor cells, the company is dedicated to increasing treatment efficacy and improving patient outcomes. With a robust portfolio of clinical candidates addressing critical unmet medical needs within oncology, Indaptus is strategically positioned for growth in an increasingly competitive market. Its dedication to scientific innovation and partnerships with leading research institutions highlights its potential as a transformative force in the biopharmaceutical sector.

5 employees
Listed August 4, 2021
HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot
SICBIOTECHNOLOGY
CIK
Composite FIGI
Share Class FIGI